Basket | Login | Register

 
 
 
 

Clinical trials by country

Phase III trials

Belgium

  1. GRADUATE 2
  2. LUCIDITY (planned)

Bulgaria

  1. 17-AVP-786-305

Croatia

  1. GRADUATE 2

Czech Republic

  1. 17-AVP-786-305

Denmark

  1. GRADUATE 2

Finland

  1. GRADUATE 2

France

  1. CLARITY-AD
  2. GAIN
  3. GRADUATE 1
  4. LO-MAPT
  5. LUCIDITY (planned)
  6. 17-AVP-786-305

Germany

  1. CLARITY-AD
  2. GRADUATE 1

Hungary

  1. GRADUATE 1
  2. 17-AVP-786-305

Italy

  1. CLARITY-AD
  2. GRADUATE 1
  3. LUCIDITY (planned)
  4. 17-AVP-786-305

Lithuania

  1. GRADUATE 1

Netherlands

  1. GAIN

Poland

  1. GAIN
  2. GRADUATE 2
  3. LUCIDITY
  4. 17-AVP-786-305

Portugal

  1. GRADUATE 2

Russia

  1. GRADUATE 1

Spain

  1. CLARITY-AD
  2. GAIN
  3. GRADUATE 1
  4. GRADUATE 2
  5. LUCIDITY (planned)
  6. 17-AVP-786-305

Sweden

  1. CLARITY-AD
  2. GRADUATE 2

Turkey

  1. GRADUATE 2

UK

  1. CLARITY-AD
  2. AIN
  3. GRADUATE 2
  4. NorAD
  5. LUCIDITY (planned)
  6. 17-AVP-786-305

 

 
 

Last Updated: Thursday 04 June 2020

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options